Getagraph.com logo
S&P 500
(0.91%) 5 064.26 points
Dow Jones
(0.87%) 38 232 points
Nasdaq
(1.48%) 15 836 points
Oil
(0.08%) $79.06
Gas
(5.69%) $2.04
Gold
(0.23%) $2 316.30
Silver
(0.54%) $26.89
Platinum
(1.11%) $965.50
USD/EUR
(-0.05%) $0.933
USD/NOK
(-0.32%) $10.99
USD/GBP
(-0.04%) $0.798
USD/RUB
(-1.36%) $91.99

Realaus laiko atnaujinimai Pulmonx Corporation [LUNG]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Medical Devices
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-07)

Expected move: +/- 6.23%

BUY
100.00%
return 2.50%
SELL
0.00%
return 4.26%
Atnaujinta2 geg. 2024 @ 21:37
25% discount on Stockinvest.us - Use code: Podcast

22.15% $ 9.43

PARDAVIMAS 112566 min ago

@ $14.55

Išleistas: 14 vas. 2024 @ 16:30

Grąža: -35.19%

Ankstesnis signalas: vas. 13 - 16:30

Ankstesnis signalas: Pirkimas

Grąža: 2.50 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 21:37):
Profile picture for Pulmonx Corporation

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation...

Stats
Šios dienos apimtis 841 025
Vidutinė apimtis 592 604
Rinkos kapitalizacija 363.41M
EPS $0 ( 2024-02-21 )
Kita pelno data ( $-0.430 ) 2024-05-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -5.89
ATR14 $0.0200 (0.21%)
Insider Trading
Date Person Action Amount type
2024-04-22 Rose Geoffrey Beran Sell 1 184 Common Stock
2024-04-03 Joshi Mehul Buy 0
2024-03-22 Rose Geoffrey Beran Sell 1 184 Common Stock
2024-03-15 Williamson Steven S. Buy 425 116 Employee Stock Option (right to buy)
2024-03-15 Williamson Steven S. Buy 205 286 Common Stock
INSIDER POWER
77.49
Last 98 transactions
Buy: 1 710 475 | Sell: 224 988

Tūris Koreliacija

Ilgas: 0.10 (neutral)
Trumpas: -0.42 (neutral)
Signal:(34.626) Neutral

Pulmonx Corporation Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Pulmonx Corporation Koreliacija - Valiuta/Žaliavos

The country flag 0.72
( moderate )
The country flag 0.56
( weak )
The country flag 0.68
( moderate )
The country flag 0.69
( moderate )
The country flag -0.02
( neutral )
The country flag -0.55
( weak negative )

Pulmonx Corporation Finansinės ataskaitos

Annual 2023
Pajamos: $68.68M
Bruto pelnas: $50.35M (73.32 %)
EPS: $-1.600
FY 2023
Pajamos: $68.68M
Bruto pelnas: $50.35M (73.32 %)
EPS: $-1.600
FY 2022
Pajamos: $53.66M
Bruto pelnas: $39.87M (74.29 %)
EPS: $-1.590
FY 2021
Pajamos: $48.42M
Bruto pelnas: $35.63M (73.59 %)
EPS: $-1.350

Financial Reports:

No articles found.

Pulmonx Corporation

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.